Angel Akinbinu, Director of Trial Equity & Representation at Takeda Pharmaceuticals, is a recognized leader in advancing diversity, equity, and inclusion (DEI) in clinical trials. With extensive experience spanning roles in CROs and large pharmaceutical organizations, she has contributed to multiple therapeutic areas. Over the past several years, Angel has distinguished herself as a driving force behind efforts to improve representation and access for underrepresented patient populations, ensuring more equitable healthcare outcomes through innovative strategies and impactful implementation. Her expertise makes her a vital advocate for inclusive clinical research.